These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28347118)

  • 1. Magnetic Nanoparticles Cross the Blood-Brain Barrier: When Physics Rises to a Challenge.
    Busquets MA; Espargaró A; Sabaté R; Estelrich J
    Nanomaterials (Basel); 2015 Dec; 5(4):2231-2248. PubMed ID: 28347118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies to overcome the barrier: use of nanoparticles as carriers and modulators of barrier properties.
    Rempe R; Cramer S; Qiao R; Galla HJ
    Cell Tissue Res; 2014 Mar; 355(3):717-26. PubMed ID: 24585360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier.
    Lim SH; Yee GT; Khang D
    Int J Nanomedicine; 2024; 19():2529-2552. PubMed ID: 38505170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simulation of magnetic nanoparticles crossing through a simplified blood-brain barrier model for Glioblastoma multiforme treatment.
    Gkountas AA; Polychronopoulos ND; Sofiadis GN; Karvelas EG; Spyrou LA; Sarris IE
    Comput Methods Programs Biomed; 2021 Nov; 212():106477. PubMed ID: 34736172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic iron oxide nanoparticles for brain imaging and drug delivery.
    Qiao R; Fu C; Forgham H; Javed I; Huang X; Zhu J; Whittaker AK; Davis TP
    Adv Drug Deliv Rev; 2023 Jun; 197():114822. PubMed ID: 37086918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders.
    Correia AC; Monteiro AR; Silva R; Moreira JN; Sousa Lobo JM; Silva AC
    Adv Drug Deliv Rev; 2022 Oct; 189():114485. PubMed ID: 35970274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of drug permeability across blood brain barrier using nanoparticles in meningitis.
    Nair KGS; Ramaiyan V; Sukumaran SK
    Inflammopharmacology; 2018 Jun; 26(3):675-684. PubMed ID: 29582240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic nanoparticles in the brain: A review of types, physicochemical properties and challenges.
    de Lima LS; Mortari MR
    Int J Pharm; 2022 Jan; 612():121367. PubMed ID: 34896565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gold nanoparticles: A plausible tool to combat neurological bacterial infections in humans.
    Rizvi SMD; Hussain T; Ahmed ABF; Alshammari TM; Moin A; Ahmed MQ; Barreto GE; Kamal MA; Ashraf GM
    Biomed Pharmacother; 2018 Nov; 107():7-18. PubMed ID: 30075371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of radiofrequency exposure on in vitro blood-brain barrier permeability in the presence of magnetic nanoparticles.
    Senturk F; Cakmak S; Kocum IC; Gumusderelioglu M; Ozturk GG
    Biochem Biophys Res Commun; 2022 Mar; 597():91-97. PubMed ID: 35134610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remote control of the permeability of the blood-brain barrier by magnetic heating of nanoparticles: A proof of concept for brain drug delivery.
    Tabatabaei SN; Girouard H; Carret AS; Martel S
    J Control Release; 2015 May; 206():49-57. PubMed ID: 25724273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain.
    Israel LL; Galstyan A; Holler E; Ljubimova JY
    J Control Release; 2020 Apr; 320():45-62. PubMed ID: 31923537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic field enhanced convective diffusion of iron oxide nanoparticles in an osmotically disrupted cell culture model of the blood-brain barrier.
    Sun Z; Worden M; Wroczynskyj Y; Yathindranath V; van Lierop J; Hegmann T; Miller DW
    Int J Nanomedicine; 2014; 9():3013-26. PubMed ID: 25018630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles as a Carrier System for Drug Delivery Across Blood Brain Barrier.
    Sarkar A; Fatima I; Jamal QMS; Sayeed U; Khan MKA; Akhtar S; Kamal MA; Farooqui A; Siddiqui MH
    Curr Drug Metab; 2017; 18(2):129-137. PubMed ID: 28088890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting the properties of biomolecules for brain targeting of nanoparticulate systems.
    Cramer S; Rempe R; Galla HJ
    Curr Med Chem; 2012; 19(19):3163-87. PubMed ID: 22612701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upconversion Nanoparticle-Based Strategy for Crossing the Blood-Brain Barrier to Treat the Central Nervous System Disease.
    Fu L; Chung R; Shi B
    Methods Mol Biol; 2019; 2054():263-282. PubMed ID: 31482461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic Nanoparticles in the Central Nervous System: Targeting Principles, Applications and Safety Issues.
    D'Agata F; Ruffinatti FA; Boschi S; Stura I; Rainero I; Abollino O; Cavalli R; Guiot C
    Molecules; 2017 Dec; 23(1):. PubMed ID: 29267188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric magnetic nanoparticles: a multitargeting approach for brain tumour therapy and imaging.
    Joshi B; Joshi A
    Drug Deliv Transl Res; 2022 Jul; 12(7):1588-1604. PubMed ID: 34537930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central nervous system delivery of molecules across the blood-brain barrier.
    Gosselet F; Loiola RA; Roig A; Rosell A; Culot M
    Neurochem Int; 2021 Mar; 144():104952. PubMed ID: 33400964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal Nanoparticles as Targeted Carriers Circumventing the Blood-Brain Barrier.
    Sintov AC; Velasco-Aguirre C; Gallardo-Toledo E; Araya E; Kogan MJ
    Int Rev Neurobiol; 2016; 130():199-227. PubMed ID: 27678178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.